276 related articles for article (PubMed ID: 1888645)
1. Aspirin-induced gastric mucosal damage: prevention by enteric-coating and relation to prostaglandin synthesis.
Hawthorne AB; Mahida YR; Cole AT; Hawkey CJ
Br J Clin Pharmacol; 1991 Jul; 32(1):77-83. PubMed ID: 1888645
[TBL] [Abstract][Full Text] [Related]
2. Protection of human gastric mucosa against aspirin-enteric coating or dose reduction?
Cole AT; Hudson N; Liew LC; Murray FE; Hawkey CJ; Heptinstall S
Aliment Pharmacol Ther; 1999 Feb; 13(2):187-93. PubMed ID: 10102949
[TBL] [Abstract][Full Text] [Related]
3. Separation of the impairment of haemostasis by aspirin from mucosal injury in the human stomach.
Hawkey CJ; Hawthorne AB; Hudson N; Cole AT; Mahida YR; Daneshmend TK
Clin Sci (Lond); 1991 Oct; 81(4):565-73. PubMed ID: 1657506
[TBL] [Abstract][Full Text] [Related]
4. Enteric coating of aspirin significantly decreases gastroduodenal mucosal lesions.
Dammann HG; Burkhardt F; Wolf N
Aliment Pharmacol Ther; 1999 Aug; 13(8):1109-14. PubMed ID: 10468689
[TBL] [Abstract][Full Text] [Related]
5. Effect of sucralfate on aspirin induced mucosal injury and impaired haemostasis in humans.
Hudson N; Murray FE; Cole AT; Filipowicz B; Hawkey CJ
Gut; 1997 Jul; 41(1):19-23. PubMed ID: 9274466
[TBL] [Abstract][Full Text] [Related]
6. Comparison of the effects of regular and enteric-coated aspirin on gastroduodenal mucosa of man.
Hoftiezer JW; Silvoso GR; Burks M; Ivey KJ
Lancet; 1980 Sep; 2(8195 pt 1):609-12. PubMed ID: 6107406
[TBL] [Abstract][Full Text] [Related]
7. Role of Helicobacter pylori infection in gastroduodenal injury and gastric prostaglandin synthesis during long term/low dose aspirin therapy: a prospective placebo-controlled, double-blind randomized trial.
Feldman M; Cryer B; Mallat D; Go MF
Am J Gastroenterol; 2001 Jun; 96(6):1751-7. PubMed ID: 11419825
[TBL] [Abstract][Full Text] [Related]
8. Reduction in gastric mucosal hemorrhage and ulceration with chronic high-level dosing of enteric-coated aspirin granules two and four times a day.
Lanza FL; Rack MF; Wagner GS; Balm TK
Dig Dis Sci; 1985 Jun; 30(6):509-12. PubMed ID: 3873326
[TBL] [Abstract][Full Text] [Related]
9. Dose effects of aspirin on gastric prostaglandins and stomach mucosal injury.
Lee M; Cryer B; Feldman M
Ann Intern Med; 1994 Feb; 120(3):184-9. PubMed ID: 8273981
[TBL] [Abstract][Full Text] [Related]
10. Double blind controlled study on the effect of sucralfate on gastric prostaglandin formation and microbleeding in normal and aspirin treated man.
Konturek SJ; Kwiecień N; Obtułowicz W; Kopp B; Oleksy J
Gut; 1986 Dec; 27(12):1450-6. PubMed ID: 3492413
[TBL] [Abstract][Full Text] [Related]
11. Low dose aspirin: selective inhibition of rectal dialysis thromboxane B2 in healthy volunteers.
Cole AT; Filipowicz B; Hyman-Taylor P; Hawkey CJ
Aliment Pharmacol Ther; 1994 Oct; 8(5):521-6. PubMed ID: 7865644
[TBL] [Abstract][Full Text] [Related]
12. Ranitidine: differential effects on gastric bleeding and mucosal damage induced by aspirin.
Cole AT; Brundell S; Hudson N; Hawthorne AB; Mahida YR; Hawkey CJ
Aliment Pharmacol Ther; 1992 Dec; 6(6):707-15. PubMed ID: 1486156
[TBL] [Abstract][Full Text] [Related]
13. Does enteric-coated aspirin result in a lower incidence of gastrointestinal complications compared to normal aspirin?
Walker J; Robinson J; Stewart J; Jacob S
Interact Cardiovasc Thorac Surg; 2007 Aug; 6(4):519-22. PubMed ID: 17669925
[TBL] [Abstract][Full Text] [Related]
14. Effects of very low dose daily, long-term aspirin therapy on gastric, duodenal, and rectal prostaglandin levels and on mucosal injury in healthy humans.
Cryer B; Feldman M
Gastroenterology; 1999 Jul; 117(1):17-25. PubMed ID: 10381905
[TBL] [Abstract][Full Text] [Related]
15. Prevention of acute aspirin-induced gastric mucosal injury by 15-R-15 methyl prostaglandin E2: an endoscopic study.
Gilbert DA; Surawicz CM; Silverstein FE; Weinberg CR; Saunders DR; Feld AD; Sanford RL; Bergman D; Washington P
Gastroenterology; 1984 Feb; 86(2):339-45. PubMed ID: 6360786
[TBL] [Abstract][Full Text] [Related]
16. Effect of prostaglandin E2 on gastric mucosal bleeding caused by aspirin.
Hunt JN; Franz DR
Dig Dis Sci; 1981 Apr; 26(4):301-5. PubMed ID: 6972294
[TBL] [Abstract][Full Text] [Related]
17. Effects of colloidal bismuth subcitrate on aspirin-induced gastric microbleeding, DNA loss, and prostaglandin formation in humans.
Konturek SJ; Kwiecień N; Obtułowicz W; Hebzda Z; Oleksy J
Scand J Gastroenterol; 1988 Sep; 23(7):861-6. PubMed ID: 3067330
[TBL] [Abstract][Full Text] [Related]
18. Reduction of endoscopically assessed acute aspirin-induced gastric mucosal injury with cimetidine.
Kimmey MB; Silverstein FE; Saunders DR; Chapman RC
Dig Dis Sci; 1987 Aug; 32(8):851-6. PubMed ID: 3301232
[TBL] [Abstract][Full Text] [Related]
19. Gastrointestinal blood loss with low dose (325 mg) plain and enteric-coated aspirin administration.
Savon JJ; Allen ML; DiMarino AJ; Hermann GA; Krum RP
Am J Gastroenterol; 1995 Apr; 90(4):581-5. PubMed ID: 7717315
[TBL] [Abstract][Full Text] [Related]
20. Salicylsalicylic acid causes less gastroduodenal mucosal damage than enteric-coated aspirin. An endoscopic comparison.
Scheiman JM; Behler EM; Berardi RR; Elta GH
Dig Dis Sci; 1989 Feb; 34(2):229-32. PubMed ID: 2914543
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
